- Home
- NYT vs SNN Comparison
NYT vs SNN Comparison
Compare NYT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NYT | SNN |
|---|---|---|
| Founded | 1851 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Newspapers/Magazines | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 14.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | NYT | SNN |
|---|---|---|
| Price | $70.75 | $30.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $72.14 | $36.25 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 05-06-2026 | 03-16-2026 |
| Dividend Yield | 1.16% | ★ 2.48% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,783,639,000.00 | N/A |
| Revenue This Year | $10.58 | $8.58 |
| Revenue Next Year | $6.98 | $5.60 |
| P/E Ratio | $127.15 | ★ $64.97 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $51.03 | $29.08 |
| 52 Week High | $87.10 | $38.79 |
Technical Indicators
Market Signals| Indicator | NYT | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 38.61 | 45.14 |
| Support Level | $69.30 | $29.10 |
| Resistance Level | $71.78 | $31.28 |
| Average True Range (ATR) | 1.92 | 0.46 |
| MACD | -0.30 | -0.00 |
| Stochastic Oscillator | 24.37 | 26.54 |
Price Performance
Historical ComparisonAbout NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company derives revenue from subscriptions, advertising, and other sources, where the majority of its revenue is generated through subscriptions, which consist of income from standalone and multiproduct bundle subscriptions to its digital products and subscriptions to and single-copy and bulk sales of print products.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.